Investigator Site 2

Barcelona

0 studies enrolling now · 3 studies all time

What they study most

Acquired Thrombotic Thrombocytopenic Purpura, Lupus Erythematosus, Systemic

Studies at this site

• Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura — Completed
• Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES) — Completed
• A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus — Completed